Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1
Clinical trial NCT06777264 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06777264
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2026-12-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.